These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28130578)

  • 21. [Interventional radiological procedures in the therapy for colorectal liver metastases].
    Damm R; Seidensticker R; Ricke J; Seidensticker M
    Zentralbl Chir; 2013 Feb; 138(1):76-83. PubMed ID: 23450396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatic metastasis of colorectal cancer--current therapeutic possibilities].
    Popescu I; Alexandrescu S
    Chirurgia (Bucur); 2010; 105(2):155-69. PubMed ID: 20540227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interventional therapy of colorectal liver metastasis].
    Zhang Q; Teng G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):621-624. PubMed ID: 28643305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "How we do it" - a practical approach to hepatic metastases ablation techniques.
    Sofocleous CT; Sideras P; Petre EN
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):219-29. PubMed ID: 24238377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.
    Xing M; Kooby DA; El-Rayes BF; Kokabi N; Camacho JC; Kim HS
    J Surg Oncol; 2014 Aug; 110(2):182-96. PubMed ID: 24760444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ablative Modalities in the Treatment of Liver Metastases].
    Schnitzbauer A; Bechstein WO; Vogl T
    Zentralbl Chir; 2019 Jun; 144(3):259-263. PubMed ID: 31167269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of interventional oncology in the treatment of colorectal cancer liver metastases.
    Tsitskari M; Filippiadis D; Kostantos C; Palialexis K; Zavridis P; Kelekis N; Brountzos E
    Ann Gastroenterol; 2019; 32(2):147-155. PubMed ID: 30837787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
    Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
    Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic Outcomes after Percutaneous Ablation for Colorectal Liver Metastases: An Updated Comprehensive Review.
    Chlorogiannis DD; Sotirchos VS; Sofocleous CT
    Medicina (Kaunas); 2024 Sep; 60(9):. PubMed ID: 39336577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonresectional regional therapies for metastatic colorectal cancer to the liver.
    Schlick CJR; Merkow RP; Bentrem DJ
    J Surg Oncol; 2019 Apr; 119(5):636-641. PubMed ID: 30825217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regional therapy of liver tumors].
    Spangenberg HC; Mohr L; Blum HE
    Internist (Berl); 2007 Jan; 48(1):40-5. PubMed ID: 17160664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
    Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ
    Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locoregional Therapies for Colorectal Cancer Liver Metastases: Options Beyond Resection.
    Uhlig J; Lukovic J; Dawson LA; Patel RA; Cavnar MJ; Kim HS
    Am Soc Clin Oncol Educ Book; 2021 Mar; 41():133-146. PubMed ID: 34010047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases?
    Vogl TJ; Emam A; Naguib NN; Eichler K; Zangos S
    Viszeralmedizin; 2015 Dec; 31(6):406-13. PubMed ID: 26889144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial approaches to primary and secondary hepatic malignancies.
    Habib A; Desai K; Hickey R; Thornburg B; Lewandowski R; Salem R
    Nat Rev Clin Oncol; 2015 Aug; 12(8):481-9. PubMed ID: 25985939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic options in non-resectable liver metastases. Percutaneous radiological interventions].
    Vogl TJ; Müller PK; Mack MG; Straub R; Engelmann K; Neuhaus P
    Chirurg; 1999 Feb; 70(2):133-40. PubMed ID: 10097852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases.
    Wasan H; Kennedy A; Coldwell D; Sangro B; Salem R
    Am J Clin Oncol; 2012 Jun; 35(3):293-301. PubMed ID: 21278562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
    Miura JT; Gamblin TC
    Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH; Bruners P; Günther RW
    Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.